BioinksBioprintingDistributed Manufacturing

BIO INX and Rousselot collaborate on materials for 3D bioprinting

Darling Ingredients’ health brand Rousselot offers online access to research and technical grade X-Pure gelatins

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

In a significant leap forward for the field of 3D bioprinting, BIO INX, a leading material developer for 3D bioprinting, proudly announces the strategic collaboration with Rousselot, a global leader in gelatin- and collagen-based solutions This collaboration underscores BIO INX’ and Rousselot’s commitment to bring 3D bioprinting technologies closer to the clinic.

As part of this collaboration, BIO INX is set to distribute Rousselot’s research and technical grade X-Pure gelatin biomaterials, renowned for their quality and reliability. The X-Pure gelatin range will be seamlessly integrated into BIO INX’ offerings, making these cutting-edge materials accessible to researchers and academics worldwide through the webshop of BIO INX.

The partnership extends beyond mere distribution, as BIO INX introduces an innovative product, the X-Pure version of their renowned extrusion bioink, GEL-MA INX. This pioneering bioink, produced in collaboration with Rousselot, is the first step towards a GMP-like gelatin-based bioink that enables printing constructs in the presence of living cells in a straightforward manner. The development is in line with the mission of BIO INX to make bioprinting turnkey. It represents a significant stride towards bringing the technology of 3D bioprinting closer to the clinic by enhancing reproducibility and standardization while adhering to the elevated quality requirements.

This collaboration builds upon a longstanding relationship between BIO INX and Rousselot. Namely, BIO INX, is a spin-off company from the Polymer Chemistry and Biomaterials Group at Ghent University, where the original Gelatin Methacryloyl (GEL-MA) was developed and patented 25 years ago using Rousselot gelatin, under the supervision of prof. Etienne Schacht. The research group is currently co-led by Professor Sandra Van Vlierberghe, one of the co-founders of BIO INX.

‘Ever since the original publication on GEL-MA in 2000, the material has grown in popularity, becoming one of the reference materials in tissue engineering and 3D bioprinting research worldwide. Now, this collaboration with Rousselot also adds reproducibility to the mix. The added standardization and quality were the missing link to bring this material from academic research to real-life applications,” commented prof. Sandra Van Vlierberghe.

“This collaboration represents the culmination of years of shared vision and innovation between BIO INX and Rousselot to increase standardization and quality in biomaterials for tissue engineering and 3D bioprinting. By integrating Rousselot’s X-Pure gelatin biomaterials into our portfolio and introducing a GMP-like bioink, we are not only advancing the capabilities of 3D bioprinting but also building further on our roots and the groundbreaking work of the research group at Ghent University before incorporation,” commented Jasper Van Hoorick, CEO of BIO INX.

Furthermore, this collaboration provides a significant boost to the Ghent region’s expertise in gelatin and gelatin-based products. The synergy of BIO INX, a leader in biomaterials for high-resolution 3D bioprinting, and Rousselot, a global leader in gelatin products, proves to be greater than the sum of its parts. This partnership is poised to enhance the region’s longstanding legacy of excellence in gelatin expertise.

Tanja Vervust, Global Director of Rousselot Biomedical stated: “Collaborating with BIO INX to offer online-purchasing streamlines the ordering process and provides efficient delivery of high-quality gelatins necessary for tissue engineering and biofabrication projects,” said Tanja Vervust, Global Director, Rousselot Biomedical. ”Rousselot’s research-grade X-Pure gelatins are functionally equivalent to GMP-grade gelatins and help to reduce development variability and facilitate the transition to clinical applications.”

Composites AM 2024

746 composites AM companies individually surveyed and studied. Core composites AM market generated over $785 million in 2023. Market expected to grow to $7.8 billion by 2033 at 25.8% CAGR. This new...

Davide Sher

Since 2002, Davide has built up extensive experience as a technology journalist, market analyst and consultant for the additive manufacturing industry. Born in Milan, Italy, he spent 12 years in the United States, where he completed his studies at SUNY USB. As a journalist covering the tech and videogame industry for over 10 years, he began covering the AM industry in 2013, first as an international journalist and subsequently as a market analyst, focusing on the additive manufacturing industry and relative vertical markets. In 2016 he co-founded London-based VoxelMatters. Today the company publishes the leading news and insights websites and, as well as VoxelMatters Directory, the largest global directory of companies in the additive manufacturing industry.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services


Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.